Long known as one of the leading life science venture capital firms based in Europe, Phase4 Partners, formerly known as Phase4 Ventures, has more recently expanded its mission to include a range of innovative investment vehicles to meet the needs of major pharmaceutical companies as well as sophisticated private and institutional investors from around the world.
| Website | http://www.phase4-partners.com |
| Revenue | $1.6 million |
| Employees | 6 (2 on RocketReach) |
| Founded | 1999 |
| Phone | +44 20 3036 0050 |
| Technologies | |
| Industry | Venture Capital and Private Equity Principals, Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
| Keywords | Venture Capital, Life Sciences, Pharmaceutical Investing, Healthcare Venture Capital, Seed Funding, Series A Funding, Private Equity, Investment Management, Portfolio Management, Due Diligence, Financial Advisory, Deal Sourcing, Exit Strategy, Growth Equity, Medical Technology, Biopharma, Drug Development, Innovation Investment, Impact Investing |
| Competitors | Deloitte, PwC, EY, Accenture, KPMG In Pakistan, McKinsey & Company, Boston Consulting Group (BCG), Bain & Company, Oliver Wyman, Roland Berger +40 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 2834 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Phase4 Partners employee's phone or email?
Phase4 Partners Questions
The Phase4 Partners annual revenue was $1.6 million in 2026.
Denise Pollard-Knight is the Managing partner of Phase4 Partners.
2 people are employed at Phase4 Partners.
The NAICS codes for Phase4 Partners are [3254, 32541, 325, 32].
The SIC codes for Phase4 Partners are [28, 283, 2834].
Top Phase4 Partners Employees
Related Companies
